Rapid Admixture Blood Warming: Fast, Safe & Inexpensive
Journal Title: BMH Medical Journal - Year 2014, Vol 1, Issue 3
Abstract
The international standard for banked blood, including packed red blood cells (PRBCs), requires keeping it at 4ºC. Patients who need rapid PRBC unit transfusions benefit tremendously from blood being warmed to body temperature (37ºC), since hypothermia resulting from rapid infusion of cold blood is a major risk factor in exanguinating patients. It increases morbidity and mortality as well as often producing other adverse reactions, including those simulating transfusion reactions. Ideally, methods to warm blood for rapid transfusion should bring the unit to body temperature (37ºC), and be rapid, safe and inexpensive.
Authors and Affiliations
Kenneth V Iserson
Keywords
Related Articles
- EP ID EP326883
- DOI -
- Views 107
- Downloads 0
Safely Navigating Patients With Hypertrophic Obstructive Cardiomyopathy (HOCM) During Anaesthesia
In order to have an uneventful peri-operative period it is imperative for anaesthesiologist to maintain patients in perfect haemodynamics. But patient's underlying cardiac status has lot to do with the patient's peri-ope...
Approach to Brugada Syndrome
Brugada Syndrome was initially described by Brugada brothers in their seminal paper published in the Journal of American College of Cardiology in 1992. The syndrome was characterized by syncopal episodes and/or sudden ca...
Device Closure of Small Ventricular Septal Defects: When and Why?
Ventricular septal defect (VSD) accounts for approximately 20-30 % of all forms of congenital heart disease (CHD). They were traditionally closed surgically in the past. The surgery though safe carries the risk of morbid...
Postpartum Sacroiliitis Due To Brucellosis
Septic sacroiliitis during postpartum period can be a diagnostic challenge, especially because the symptoms are usually nonspecific. A 28 year old lady presented to the orthopaedic department with complaints of left glut...
The Use of Intravitreal Aflibercept in the Treatment of Wet Type of Age Related Macular Degeneration
Aflibercept, an anti vascular endothelial growth factor (anti-VEGF) which was originally developed in the treatment of large bowel cancers, has been found to be effective in the treatment of wet type of age related macul...